Efficient CRISPR/Cas9‐Mediated Mutagenesis in Primary Murine T Lymphocytes
Current Protocols in Immunology · 2019-02 · 124 (1)
DOI: 10.1002/cpim.62 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Protocols in Immunology, online erschienen am 12.10.2018. Verfasst von Bonnie Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland. Hauptthemen laut MEDLINE: Mutagenesis. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, Intramural NIH HHS, National Human Genome Research Institute.
Abstract (Originalsprache)
The ability to alter gene expression directly in T lymphocytes has provided a powerful tool for understanding T cell biology, signaling, and function. Manipulation of T cell clones and primary T cells has been accomplished primarily through overexpression or gene‐silencing studies using cDNAs or shRNAs, respectively, which are often delivered by retroviral or lentiviral transduction or direct transfection methods. The recent development of CRISPR/Cas9‐based mutagenesis has revolutionized genomic editing, allowing unprecedented genetic manipulation of many cell types with greater precision and ease. This article outlines a protocol for CRISPR/Cas9‐mediated mutagenesis in primary T lymphocytes from Cas9 transgenic mice using retroviral delivery of guide RNAs. © 2018 by John Wiley & Sons, Inc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland.
- Genetic Disease Research Branch, National Human Genome Research Institute, Bethesda, Maryland.
Förderung
- Wellcome Trust
- Intramural NIH HHS
- National Human Genome Research Institute
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Huang, B., Johansen, K. H., & Schwartzberg, P. L. (2019). Efficient CRISPR/Cas9‐Mediated Mutagenesis in Primary Murine T Lymphocytes. Current Protocols in Immunology, 124(1). https://doi.org/10.1002/cpim.62
Vancouver
Huang B, Johansen KH, Schwartzberg PL. Efficient CRISPR/Cas9‐Mediated Mutagenesis in Primary Murine T Lymphocytes. Current Protocols in Immunology. 2019;124(1). doi:10.1002/cpim.62
BibTeX
@article{Huang2019,
author = {Huang, Bonnie and Johansen, Kristoffer Haurum and Schwartzberg, Pamela L},
title = {Efficient CRISPR/Cas9‐Mediated Mutagenesis in Primary Murine T Lymphocytes},
journal = {Current Protocols in Immunology},
year = {2019},
volume = {124},
number = {1},
doi = {10.1002/cpim.62}
}
EUVIMED